• HOME
  • Business
  • Stock
  • Property
  • Market
  • Economy
  • Crypto
Language:
×
  • Home
  • tags Hilleman Labs

Hilleman Labs News

Business

Aurobindo Pharma's Subsidiary Ends Partnership with Hilleman Labs on Pediatric Vaccine Development

Olivia Carter 07 Mar, 2025

Aurobindo Pharma's subsidiary, Auro Vaccines Pvt Ltd, has terminated its licensing agreement with Hilleman Laboratories for a pediatric pentavalent vaccine. The termination, effect...

Popular News

  • Business

    India Delays Adoption of 3D X-ray Scanners for Cabin Bags Amid Security Concerns

    16 Dec, 2024
  • Economy

    South Korea's Semiconductor Boom Drives Record Current Account Surplus in May

    07 Jul, 2025
  • Business

    Pai Machines Acquires L&T Construction Equipment Division: A Strategic Leap into India's Growing Construction Sector

    12 Dec, 2024
  • Market

    Asia-Pacific Markets Rally as US-Japan Trade Talks Show 'Big Progress', Boosting Investor Confidence

    17 Apr, 2025
  • Business

    Israel Signs Major Air Defense Deal with Slovakia, Strengthening Defense Exports

    23 Dec, 2024
  • Business

    Biogen Surges with a 6% Revenue Increase to $2.4 Billion in Q1 2025

    02 May, 2025
  • Market

    Premarket Plunge: Wall Street Braces for Uncertainty Ahead of Trump's Presidency

    31 Dec, 2024
  • Business

    Xiaomi Unveils Revolutionary MiDashengLM-7B: The Future of AI Voice Recognition

    04 Aug, 2025

Newsletter

Subscribe Newsletter!

Stay ahead of the market – subscribe now for the latest insights and expert analysis delivered straight to your inbox!

About Us

  • EconWatcher.com is a comprehensive financial website dedicated to providing insights into economics, stocks, real estate, cryptocurrencies, markets, and business trends.
  • 15 Cliff St, New York NY 10038, USA
  • +91 234 567 8765
  • [email protected]

Popular Categories

  • Business (1M+)
  • Stock (1M+)
  • Property (1M+)
  • Market (1M+)
  • Economy (1M+)
  • Crypto (1M+)

Legal

  • Privacy Policy

  • Terms & Conditions

  • Contact Us

Copyright © 2022 All Rights Reserved.